Apple Cider Vinegar Research

This systematic review and dose-response meta-analysis specifically examined the effects of apple cider vinegar on glycemic control and insulin sensitivity in patients with type 2 diabetes. The researchers searched three medical databases through November 2024 and assessed study quality using both the Cochrane risk-of-bias tool and the GRADE framework for certainty of evidence.

Seven controlled clinical trials met the inclusion criteria. The pooled analysis found that ACV significantly reduced fasting blood sugar by 21.93 mg/dL (p < 0.001) and HbA1c by 1.53% (p = 0.008) in type 2 diabetes patients. Interestingly, insulin levels increased by 2.06 uU/mL, though HOMA-IR (a measure of insulin resistance) showed no significant change.

A key contribution of this study is the dose-response analysis, which found a linear relationship between ACV intake and blood sugar reduction: each additional 1 mL/day of ACV was associated with a 1.26 mg/dL decrease in fasting blood sugar. Greater effects were observed at dosages exceeding 10 mL/day. These findings provide the most specific dosing guidance available for ACV in diabetes management.

This systematic review and meta-analysis pooled data from clinical trials to evaluate the effects of apple cider vinegar (ACV) supplementation on cardiometabolic risk factors including blood glucose, lipid profiles, and body weight.

The analysis found that ACV intake led to statistically significant reductions in fasting blood glucose, HbA1c (a marker of long-term blood sugar control), total cholesterol, and triglycerides. These findings suggest ACV may have meaningful benefits for metabolic health, particularly in populations at risk of type 2 diabetes and cardiovascular disease.

The authors noted that while results were promising, the included trials varied in dosage, duration, and population characteristics. They recommended larger, longer-duration RCTs to confirm optimal dosing protocols and to determine whether these cardiometabolic improvements translate into reduced clinical events over time.

This systematic review and meta-analysis examined randomized controlled trials investigating the effect of apple cider vinegar (ACV) intake on body composition parameters in people with type 2 diabetes and/or overweight/obesity.

The pooled analysis demonstrated that ACV supplementation led to statistically significant reductions in body weight, body mass index (BMI), and waist circumference compared to placebo. The effects were consistent across studies, though the magnitude of weight loss was modest.

The authors highlighted that ACV may support weight management as a complementary approach alongside dietary and lifestyle modifications. However, they noted heterogeneity in study designs, dosages, and intervention durations, and called for larger, well-designed RCTs to establish standardized dosing recommendations and long-term efficacy.

This randomized, double-blind, placebo-controlled trial investigated the effects of daily apple cider vinegar (ACV) consumption on weight management in Lebanese adolescents and young adults with overweight and obesity.

Participants consumed ACV or a placebo daily over a 12-week period. The ACV group experienced significant reductions in body weight, BMI, waist circumference, and waist-to-hip ratio compared to the placebo group. Blood glucose and triglyceride levels also improved in the ACV group.

The study provides robust RCT evidence supporting ACV as a practical, low-cost adjunct for weight management in younger populations. The double-blind, placebo-controlled design strengthens the findings, though the authors acknowledged that the study was conducted in a single geographic population and that longer follow-up is needed to assess weight maintenance after discontinuation.

This systematic review and meta-analysis evaluated the effects of apple cider vinegar (ACV) consumption on lipid profiles and glycemic parameters across randomized clinical trials. The researchers searched medical databases through January 2020 and included studies that tested ACV alone (not combined with other interventions) for at least 2 weeks.

Nine studies comprising 10 study arms met the inclusion criteria. Using random-effects meta-analysis, the authors found that ACV consumption significantly decreased serum total cholesterol by 6.06 mg/dL and fasting plasma glucose by 7.97 mg/dL, along with meaningful reductions in HbA1c concentrations. However, no significant changes were observed in LDL cholesterol, HDL cholesterol, fasting insulin, or HOMA-IR.

Subgroup analyses revealed that the benefits were most pronounced in type 2 diabetic patients consuming 15 mL or less daily for periods longer than 8 weeks. The authors concluded that ACV consumption can beneficially affect blood lipid levels and fasting plasma glucose, positioning it as a potential adjunct dietary intervention for metabolic health.

Systematic review evaluating the evidence for apple cider vinegar as a weight loss intervention in humans.

This systematic review and meta-analysis investigated whether vinegar consumption improves glycemic control in adults with type 2 diabetes. The researchers conducted a comprehensive search across six databases (CINAHL, EMBASE, Medline, PubMed, Scopus, and Cochrane Library) through April 2019 and used the Cochrane risk-of-bias tool to assess study quality.

From 356 initially identified records, six interventional studies involving 317 patients with type 2 diabetes met the inclusion criteria. The random-effects meta-analysis demonstrated that vinegar consumption led to significantly better fasting blood glucose and HbA1c levels compared to controls. As secondary outcomes, total cholesterol and LDL cholesterol also showed notable reductions.

The authors noted several limitations, including variation in vinegar content across studies and relatively small sample sizes. Nevertheless, they concluded that clinicians could consider incorporating vinegar consumption as part of dietary advice for diabetes patients. This study is notable for being published in a nursing journal, reflecting the growing interest in practical, low-cost dietary interventions that healthcare providers can recommend alongside standard diabetes management.

This systematic review and meta-analysis evaluated the effect of vinegar consumption on postprandial glycemic and insulin responses across multiple studies.

This double-blind, placebo-controlled trial examined the effects of daily vinegar consumption on body composition in obese Japanese adults.

Participants consuming 15-30ml of vinegar daily for 12 weeks showed significant reductions in body weight, BMI, visceral fat area, and serum triglyceride levels compared to placebo.

This crossover study examined whether vinegar consumption before meals could improve glucose and insulin responses.

Results showed that 20g of apple cider vinegar consumed before a high-carbohydrate meal significantly improved insulin sensitivity and reduced post-meal blood glucose in both insulin-resistant individuals and type 2 diabetics.